Correlation Between Coya Therapeutics, and Better Therapeutics
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Better Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Better Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and Better Therapeutics, you can compare the effects of market volatilities on Coya Therapeutics, and Better Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Better Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Better Therapeutics.
Diversification Opportunities for Coya Therapeutics, and Better Therapeutics
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Coya and Better is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Better Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Better Therapeutics and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Better Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Better Therapeutics has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Better Therapeutics go up and down completely randomly.
Pair Corralation between Coya Therapeutics, and Better Therapeutics
Given the investment horizon of 90 days Coya Therapeutics, Common is expected to generate 0.67 times more return on investment than Better Therapeutics. However, Coya Therapeutics, Common is 1.49 times less risky than Better Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Better Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 457.00 in Coya Therapeutics, Common on September 14, 2024 and sell it today you would earn a total of 117.00 from holding Coya Therapeutics, Common or generate 25.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 29.21% |
| Values | Daily Returns |
Coya Therapeutics, Common vs. Better Therapeutics
Performance |
| Timeline |
| Coya Therapeutics, Common |
| Better Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Coya Therapeutics, and Better Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Coya Therapeutics, and Better Therapeutics
The main advantage of trading using opposite Coya Therapeutics, and Better Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Better Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Better Therapeutics will offset losses from the drop in Better Therapeutics' long position.| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Acumen Pharmaceuticals |
| Better Therapeutics vs. ABVC Biopharma | Better Therapeutics vs. Indaptus Therapeutics | Better Therapeutics vs. Pasithea Therapeutics Corp | Better Therapeutics vs. Forte Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |